ANI PHARMACEUTICALS, INC

ANIP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-47.5M
Depreciation & Amortization $137.3K
Depreciation
Amortization
Stock-Based Compensation $1.3M
Net Cash from Operating Activities $-18.4M
Investing Activities
Capital Expenditures $165.7K
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities
Net Change in Cash
Free Cash Flow $-18.6M
← Newer Page 3 of 3 Older →